Mitochondria‐Targeted Supramolecular Nanoparticles Alleviate Cellular Senescence by Restoring Mitochondrial Homeostasis in Osteoarthritis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yuan Hui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Cellular Senescence, Nanoparticles, Osteoarthritis, Mitochondria. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital.
Abstract (Originalsprache)
Osteoarthritis (OA) is a common age‐related degenerative joint disorder with no effective disease‐modifying drugs. Cellular senescence and mitochondrial dysfunction that disrupt chondrocyte homeostasis are key drivers of OA initiation and progression. Here, we develop mitochondria‐targeted supramolecular nanoparticles (EG NPs) self‐assembled from Epigallocatechin‐3‐gallate (EGCG) and L‐Glutamic acid (L‐Glu), enabling efficient scavenging of mitochondrial reactive oxygen species (mtROS) through targeted delivery and ultimately restoring mitochondrial homeostasis. This leads to reduced DNA damage, inhibition of the NF‐κB inflammatory signaling pathway, and attenuation of cellular senescence along with its associated inflammatory senescence‐associated secretory phenotype (SASP). Simultaneously, mitochondria‐targeted EG NPs promote mitochondrial inner and outer membrane fusion and biogenesis by upregulating fusion markers and activating the AMPK pathway, enhancing energy supply, alleviating cellular senescence, and promoting matrix synthesis in chondrocytes. In vivo experiments in a mouse OA model prove that EG NPs markedly suppress synovial inflammation, alleviate articular cartilage damage and matrix degradation, and ameliorate abnormal subchondral bone remodeling, thereby preserving cartilage structural integrity and effectively slowing OA progression. This multifunctional mitochondria‐targeted nanoplatform, centered on restoring mitochondrial homeostasis, precisely modulates the function of senescent chondrocytes and alleviates their senescent phenotype, establishing a promising new paradigm for OA therapy and opening new avenues for nanotechnology‐based interventions in aging‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Orthopedics, Guizhou Provincial People's Hospital, Guiyang, China.
ORCID-Profile: Yuan Hui, Yifang Bao, Jingfeng Li, Renxiong Wei
Förderung
- Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital
Zitieren
APA
Hui, Y., Bao, Y., Yang, Z., Jiang, Z., Tang, S., Chang, K., Shi, G., Li, J., & Wei, R. (2026). Mitochondria‐Targeted Supramolecular Nanoparticles Alleviate Cellular Senescence by Restoring Mitochondrial Homeostasis in Osteoarthritis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71831
Vancouver
Hui Y, Bao Y, Yang Z, Jiang Z, Tang S, Chang K, et al. Mitochondria‐Targeted Supramolecular Nanoparticles Alleviate Cellular Senescence by Restoring Mitochondrial Homeostasis in Osteoarthritis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71831
BibTeX
@article{Hui2026,
author = {Hui, Yuan and Bao, Yifang and Yang, Zhiqiang and Jiang, Zhiyu and Tang, Shunjie and Chang, Ke and Shi, Guang and Li, Jingfeng and Wei, Renxiong},
title = {Mitochondria‐Targeted Supramolecular Nanoparticles Alleviate Cellular Senescence by Restoring Mitochondrial Homeostasis in Osteoarthritis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71831}
}
EUVIMED